Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension
Dinesh Mani Tripathi, Marina Vilaseca, Erica Lafoz, et al.
Gastroenterology (2018) Vol. 155, Iss. 5, pp. 1564-1577
Open Access | Times Cited: 114

Showing 1-25 of 114 citing articles:

Role of liver sinusoidal endothelial cells in liver diseases
Jordi Gracia‐Sancho, Esther Caparrós, Anabel Fernández‐Iglesias, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 6, pp. 411-431
Closed Access | Times Cited: 257
Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction
Cornelius Engelmann, J. J. Clariá, Gyöngyi Szabó, et al.
Journal of Hepatology (2021) Vol. 75, pp. S49-S66
Open Access | Times Cited: 252
Hepatic microcirculation and mechanisms of portal hypertension
Jordi Gracia‐Sancho, Giusi Marrone, Anabel Fernández‐Iglesias
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 16, Iss. 4, pp. 221-234
Closed Access | Times Cited: 207
Animal models for liver disease – A practical approach for translational research
Yulia A. Nevzorova, Zoé Boyer-Díaz, Francisco Javier Cubero, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 2, pp. 423-440
Open Access | Times Cited: 192
Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice
Xiaogang Xiang, Dechun Feng, Seonghwan Hwang, et al.
Journal of Hepatology (2019) Vol. 72, Iss. 4, pp. 736-745
Open Access | Times Cited: 148
Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure
Jonel Trebicka, Peer Bork, Aleksander Krag, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 18, Iss. 3, pp. 167-180
Closed Access | Times Cited: 145
Acute-on-Chronic Liver Failure Clinical Guidelines
Jasmohan S. Bajaj, Jacqueline G. O’Leary, Jennifer C. Lai, et al.
The American Journal of Gastroenterology (2022)
Open Access | Times Cited: 140
AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis
David E. Kaplan, Cristina Ripoll, Maja Thiele, et al.
Hepatology (2023) Vol. 79, Iss. 5, pp. 1180-1211
Open Access | Times Cited: 132
Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease
Zoé Boyer-Díaz, Peio Aristu-Zabalza, María Andrés‐Rozas, et al.
Journal of Hepatology (2020) Vol. 74, Iss. 5, pp. 1188-1199
Open Access | Times Cited: 120
Cirrhosis as new indication for statins
Jaime Bosch, Jordi Gracia‐Sancho, Juan G. Abraldeṣ
Gut (2020) Vol. 69, Iss. 5, pp. 953-962
Closed Access | Times Cited: 111
Rilpivirine attenuates liver fibrosis through selective STAT1-mediated apoptosis in hepatic stellate cells
Alberto Martí-Rodrigo, Fernando Alegre, Ángela B. Moragrega, et al.
Gut (2019) Vol. 69, Iss. 5, pp. 920-932
Closed Access | Times Cited: 98
Acute-on-chronic liver failure: far to go—a review
Jinjin Luo, Jiaqi Li, Peng Li, et al.
Critical Care (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 23
A machine learning based algorithm accurately stages liver disease by quantification of arteries
Zhengxin Li, Xin Sun, Zhimin Zhao, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Acute kidney injury spectrum in patients with chronic liver disease: Where do we stand?
Wiwat Chancharoenthana, Asada Leelahavanichkul
World Journal of Gastroenterology (2019) Vol. 25, Iss. 28, pp. 3684-3703
Open Access | Times Cited: 73
The search for disease-modifying agents in decompensated cirrhosis: From drug repurposing to drug discovery
Paolo Caraceni, Juan G. Abraldeṣ, Pere Ginès, et al.
Journal of Hepatology (2021) Vol. 75, pp. S118-S134
Open Access | Times Cited: 45
Statin exposure is associated with reduced development of acute-on-chronic liver failure in a Veterans Affairs cohort
Nadim Mahmud, Sara E. Chapin, David S. Goldberg, et al.
Journal of Hepatology (2022) Vol. 76, Iss. 5, pp. 1100-1108
Open Access | Times Cited: 31
Acute-on-chronic liver failure (ACLF) in 2022: have novel treatment paradigms already arrived?
Nadir Abbas, Neil Rajoriya, Ahmed M. Elsharkawy, et al.
Expert Review of Gastroenterology & Hepatology (2022) Vol. 16, Iss. 7, pp. 639-652
Open Access | Times Cited: 30
Early Diagnosis and Prevention of Infections in Cirrhosis
Anand V. Kulkarni, Madhumita Premkumar, Juan Pablo Arab, et al.
Seminars in Liver Disease (2022) Vol. 42, Iss. 03, pp. 293-312
Open Access | Times Cited: 29
Sepsis-induced endothelial dysfunction drives acute-on-chronic liver failure through Angiopoietin-2-HGF-C/EBPβ pathway
Grant Elias, Michael Schonfeld, Sara Saleh, et al.
Hepatology (2023) Vol. 78, Iss. 3, pp. 803-819
Open Access | Times Cited: 16
Aging Influences Hepatic Microvascular Biology and Liver Fibrosis in Advanced Chronic Liver Disease
Raquel Maeso‐Díaz, Martí Ortega‐Ribera, Erica Lafoz, et al.
Aging and Disease (2019) Vol. 10, Iss. 4, pp. 684-684
Open Access | Times Cited: 47
Comprehensive evaluation of effects and safety of statin on the progression of liver cirrhosis: a systematic review and meta-analysis
Yue Gu, Xueqin Yang, Liang Wen Hang, et al.
BMC Gastroenterology (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 45
Aging and Chronic Liver Disease
Raquel Maeso‐Díaz, Jordi Gracia‐Sancho
Seminars in Liver Disease (2020) Vol. 40, Iss. 04, pp. 373-384
Closed Access | Times Cited: 42
The Role of Vascular Injury and Congestion in the Pathogenesis of Cirrhosis: the Congestive Escalator and the Parenchymal Extinction Sequence
Ian R. Wanless
Current Hepatology Reports (2020) Vol. 19, Iss. 1, pp. 40-53
Open Access | Times Cited: 41
Molecular characterization of chronic liver disease dynamics: From liver fibrosis to acute-on-chronic liver failure
Isabel Graupera, Laura Isus, Mar Coll, et al.
JHEP Reports (2022) Vol. 4, Iss. 6, pp. 100482-100482
Open Access | Times Cited: 27
Use of statins after liver transplantation is associated with improved survival: results of a nationwide study
Chiara Becchetti, Melisa Dirchwolf, Jonas Schropp, et al.
Alimentary Pharmacology & Therapeutics (2022) Vol. 56, Iss. 7, pp. 1194-1204
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top